We have located links that may give you full text access.
Association of echocardiography-related parameters with the prognosis of liver cirrhosis: a retrospective cohort study.
Current Medical Research and Opinion 2024 Februrary 20
BACKGROUND: Cardiac morphology and function, which are conventionally evaluated by echocardiography, are often abnormal in decompensated cirrhosis. We aimed to evaluate the association of echocardiography-related parameters with prognosis in cirrhosis.
METHODS: This retrospective study included 104 decompensated cirrhotic patients, in whom cardiac structure and function were measured by echocardiography, including mitral inflow early diastolic velocity/mitral inflow late diastolic velocity (E/A), left atrium diameter, left ventricular end-diastolic dimension, interventricular septal thickness, left ventricular posterior wall thickness, right atrial transverse diameter, right atrial longitudinal diameter, right ventricular dimension (RVD), stroke volume, cardiac output, left ventricular ejection fraction, and fractional shortening. Cox regression and competing risk analyses and Kaplan-Meier and Nelson-Aalen cumulative risk curves were used to evaluate their associations with further decompensation and death in cirrhotic patients, if appropriate.
RESULTS: Lower RVD was a predictor of further decompensation in Cox regression (adjusted by Child-Pugh score: P = 0.138; adjusted by MELD score: P = 0.034) and competing risk analyses (P = 0.003), and RVD ≤17 mm was significantly associated with higher cumulative incidence of further decompensation in Kaplan-Meier (P = 0.002) and Nelson-Aalen cumulative risk curves (P = 0.002). E/A ≤0.8 was a significant predictor of death in Cox regression (adjusted by Child-Pugh score: P = 0.041; adjusted by MELD score: P = 0.045) and competing risk analyses (P = 0.024), and E/A ≤0.8 was significantly associated with higher cumulative incidence of death in Kaplan-Meier (P = 0.023) and Nelson-Aalen cumulative risk curves (P = 0.024). Other echocardiography-related parameters were not significantly associated with further decompensation or death.
CONCLUSION: RVD and E/A may be considered for the prognostic assessment of decompensated cirrhosis.
METHODS: This retrospective study included 104 decompensated cirrhotic patients, in whom cardiac structure and function were measured by echocardiography, including mitral inflow early diastolic velocity/mitral inflow late diastolic velocity (E/A), left atrium diameter, left ventricular end-diastolic dimension, interventricular septal thickness, left ventricular posterior wall thickness, right atrial transverse diameter, right atrial longitudinal diameter, right ventricular dimension (RVD), stroke volume, cardiac output, left ventricular ejection fraction, and fractional shortening. Cox regression and competing risk analyses and Kaplan-Meier and Nelson-Aalen cumulative risk curves were used to evaluate their associations with further decompensation and death in cirrhotic patients, if appropriate.
RESULTS: Lower RVD was a predictor of further decompensation in Cox regression (adjusted by Child-Pugh score: P = 0.138; adjusted by MELD score: P = 0.034) and competing risk analyses (P = 0.003), and RVD ≤17 mm was significantly associated with higher cumulative incidence of further decompensation in Kaplan-Meier (P = 0.002) and Nelson-Aalen cumulative risk curves (P = 0.002). E/A ≤0.8 was a significant predictor of death in Cox regression (adjusted by Child-Pugh score: P = 0.041; adjusted by MELD score: P = 0.045) and competing risk analyses (P = 0.024), and E/A ≤0.8 was significantly associated with higher cumulative incidence of death in Kaplan-Meier (P = 0.023) and Nelson-Aalen cumulative risk curves (P = 0.024). Other echocardiography-related parameters were not significantly associated with further decompensation or death.
CONCLUSION: RVD and E/A may be considered for the prognostic assessment of decompensated cirrhosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app